Journals / Turkish Journal of Medical Sciences / 2011 / Cilt: 41 - Sayı: 6

Kilo verme diyetleri hakkında bazı etik düşünceler

Some ethical refl ections on weight-loss diets

Pages
951–957
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In order to overcome such sort of abuses, the authority of conventional medicine should be emphasized, drug production should be carefully controlled, and misinformation dealt out by non-specialists’ advices and the unqualifi ed promotion of herbal recipes through media communication should be prevented.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: To assess how weight-loss diets tend to move away from the authority of conventional medicine and become a field of abuse.
📊
Key Findings & Data:Several weight-loss drugs are introduced to the market without adequate controls and then have to be withdrawn after having caused serious damage to the health of a significant number of users – and after producing large profi ts for the providers.
💡
Conclusion & Impact:In order to overcome such sort of abuses, the authority of conventional medicine should be emphasized, drug production should be carefully controlled, and misinformation dealt out by non-specialists’ advices and the unqualifi ed promotion of herbal recipes through media communication should be prevented.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: To assess how weight-loss diets tend to move away from the authority of conventional medicine and become a field of abuse. Endocrinologists and specialists on metabolic diseases are rarely called upon to speak about obesity, whereas physicians from unrelated fields or nonphysicians frequently appear in the media. Materials and methods: The literature related with the field was reviewed and interpreted from an ethical perspective. Results: It is presented medically doubtful solutions via television and the internet. Several weight-loss drugs are introduced to the market without adequate controls and then have to be withdrawn after having caused serious damage to the health of a significant number of users – and after producing large profi ts for the providers. Conclusion: The main purpose is actually gaining money or popularity rather than curing people’s weight problems. Attitudes, which are far from conforming to human responsibility and the ethical principle of not causing harm, are tainting the reputation of pharmacology. In order to overcome such sort of abuses, the authority of conventional medicine should be emphasized, drug production should be carefully controlled, and misinformation dealt out by non-specialists’ advices and the unqualifi ed promotion of herbal recipes through media communication should be prevented.

Özet

Amaç: Endokrinoloji ve metabolizma hastalıkları uzmanlarına obezite konusunda nadiren söz verilirken, ilgisiz branşlardan hekimler ya da hekim dahi olmayan kimseler sık sık medyada yer almaktadır. Bu çalışmanın amacı, kilo verme diyetlerinin klasik tıbbın hakimiyetinden çıkıp bir suistimal alanı haline gelişini irdelemektir. Yöntem ve gereç: Konu ile ilgili literatür taranarak, elde edilen bilgiler etik perspektiften yorumlanmıştır. Bulgular: Kilo verme diyetleri ile ilgili olarak, televizyon ve internet aracılığı ile tıbbi dayanağı şüpheli çözümler sunulmaktadırlar. Çeşitli zayıflama ilaçları yeterince tetkik edilmeden kolayca piyasaya sürülmekte; ciddi sayıda insanı sıhhen olumsuz etkiledikten – ve kar edildikten – sonra geri çekilmektedir. Sonuç: Kilo verme diyetlerinde genel olarak para ya da popülarite hedefl enmektedir. İnsani sorumluluktan uzak, zarar vermeme ilkesine kayıtsız bu gibi tutumlar farmakolojiyi lekelemektedir. Söz konusu suistimallerin üstesinden gelmek için, geleneksel tıbbın otoritesi vurgulanmalı, ilaç üretimi daha hassas bir kontrole tabi tutulmalı; özel ihtisası olmayan kişilerin, bitkisel reçete ve tavsiyelerinin, iletişim organları kanalıyla yarattığı bilgi kirliliği önlenmelidir.

🔖

Cite This Article

ERTİN, H., ÖZALTAY, B. (2022). Kilo verme diyetleri hakkında bazı etik düşünceler. Turkish Journal of Medical Sciences, Cilt: 41 - Sayı: 6, 951–957. https://ajindex.com/articles/611328

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. WHO. The Milan Declaration: Positioning Technology to Serve Global Heart Health; 2004. Available from: URL: http:// www.who.int/cardiovascular_diseases/media/en/cvd_milan_ declaration.pdf. Accessed on 10 September 2010
  2. Hill AJ, Kirk SFL. Bulimia nervosa. In: Caballero B, Allen L, Prentice A, editors. Encyclopedia of human nutrition. 2nd ed. Elsevier Academic Press; 2005. p.74-80
  3. WHO. The ICD-10 classification of mental and behavioural disorders: diagnostic criteria for research. Geneva: World Health Organization; 1993
  4. Roerig JL, Steffen KJ, Mitchell JE, Zunker C. Laxative abuse: epidemiology, diagnosis and management. Drugs 2010; 70: 1487-503
  5. Franko DL, Becker AE, Thomas JJ, Herzog DB. Cross-ethnic differences in eating disorder symptoms and related distress. Int J Eat Disord 2007; 40: 156-64
  6. Becker AE, Burwell RA, Herzog DB, Hamburg P, Gilman SE. Eating behaviours and attitudes following prolonged exposure to television among ethnic Fijian adolescent girls. Br J Psychiatry 2002; 180: 509-14
  7. Williams LK, Ricciardelli LA, McCabe MP, Waqa GG, Bavadra K. Body image attitudes and concerns among indigenous Fijian and European Australian adolescent girls. Body Image 2006; 3: 275-87
  8. Xu X, Mellor D, Kiehne M, Ricciardelli LA, McCabe MP, Xu Y. Body dissatisfaction, engagement in body change behaviors and sociocultural infl uences on body image among Chinese adolescents. Body Image 2010; 7: 156-64
  9. Yeh HW, Tzeng NS, Chu H, Chou YH, Lu RB, O’Brien AP et al. The risk of eating disorders among female undergraduates in Taiwan. Arch Psychiatr Nurs 2009; 23: 430-40
  10. Torpy JM, Burke AE, Glass RM. Anorexia nervosa. JAMA 2006; 295: 2684
  11. Duvvuri V, Kaye WH. Anorexia nervosa. Focus: The Journal of Lifelong Learning in Psychiatry 2009; 7: 455-62
  12. Miranda EJ, McIntyre IM, Parker DR, Gary RD, Logan BK. Two deaths attributed to the use of 2,4-dinitrophenol. J Anal Toxicol 2006; 30: 219-22
  13. US Department of Health and Human Services, Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological profile for dinitrophenols. Atlanta (GA): ATSDR; 1995. Available from: URL: http://www.atsdr.cdc.gov/toxprofi les/ tp64.pdf. Accessed on 10 September 2010
  14. Colman E. Dinitrophenol and obesity: an early twentiethcentury regulatory dilemma. Regul Toxicol Pharmacol 2007; 48: 115-7
  15. Horner WD. A study of dinitrophenol and its relation to cataract formation. Trans Am Ophthalmol Soc 1941; 39: 405- 37
  16. Rasmussen N. On speed: t